125 related articles for article (PubMed ID: 11124057)
21. Retargeting of adenoviral vectors to neurons using the Hc fragment of tetanus toxin.
Schneider H; Groves M; Mühle C; Reynolds PN; Knight A; Themis M; Carvajal J; Scaravilli F; Curiel DT; Fairweather NF; Coutelle C
Gene Ther; 2000 Sep; 7(18):1584-92. PubMed ID: 11021597
[TBL] [Abstract][Full Text] [Related]
22. Localized gene delivery using antibody tethered adenovirus from polyurethane heart valve cusps and intra-aortic implants.
Stachelek SJ; Song C; Alferiev I; Defelice S; Cui X; Connolly JM; Bianco RW; Levy RJ
Gene Ther; 2004 Jan; 11(1):15-24. PubMed ID: 14681693
[TBL] [Abstract][Full Text] [Related]
23. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of costimulation allows for repeated systemic administration of adenoviral vector in rhesus monkeys.
Haegel-Kronenberger H; Haanstra K; Ziller-Remy C; Ortiz Buijsse AP; Vermeiren J; Stoeckel F; Van Gool SW; Ceuppens JL; Mehtali M; De Boer M; Jonker M; Boon L
Gene Ther; 2004 Feb; 11(3):241-52. PubMed ID: 14737083
[TBL] [Abstract][Full Text] [Related]
25. Comparative analysis of adenoviral transgene delivery via tail or portal vein into rat liver.
Herrmann J; Abriss B; van de Leur E; Weiskirchen S; Gressner AM; Weiskirchen R
Arch Virol; 2004 Aug; 149(8):1611-7. PubMed ID: 15290384
[TBL] [Abstract][Full Text] [Related]
26. RNA interference targeting the ACE gene reduced blood pressure and improved myocardial remodelling in SHRs.
He J; Bian Y; Gao F; Li M; Qiu L; Wu W; Zhou H; Liu G; Xiao C
Clin Sci (Lond); 2009 Feb; 116(3):249-55. PubMed ID: 18605985
[TBL] [Abstract][Full Text] [Related]
27. Fibroblast growth factor 2-retargeted adenoviral vectors exhibit a modified biolocalization pattern and display reduced toxicity relative to native adenoviral vectors.
Printz MA; Gonzalez AM; Cunningham M; Gu DL; Ong M; Pierce GF; Aukerman SL
Hum Gene Ther; 2000 Jan; 11(1):191-204. PubMed ID: 10646650
[TBL] [Abstract][Full Text] [Related]
28. Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area.
Kügler S; Kilic E; Bähr M
Gene Ther; 2003 Feb; 10(4):337-47. PubMed ID: 12595892
[TBL] [Abstract][Full Text] [Related]
29. Gene therapy progress and prospects: adenoviral vectors.
St George JA
Gene Ther; 2003 Jul; 10(14):1135-41. PubMed ID: 12833122
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of corneal neovascularization by recombinant adenovirus-mediated sFlk-1 expression.
Yu H; Wu J; Li H; Wang Z; Chen X; Tian Y; Yi M; Ji X; Ma J; Huang Q
Biochem Biophys Res Commun; 2007 Oct; 361(4):946-52. PubMed ID: 17692288
[TBL] [Abstract][Full Text] [Related]
31. Adenovirus-mediated gene transfer to orthotopic hepatocellular carcinomas in athymic nude mice.
Yoon SK; Armentano D; Wands JR; Mohr L
Cancer Gene Ther; 2001 Aug; 8(8):573-9. PubMed ID: 11571535
[TBL] [Abstract][Full Text] [Related]
32. Trans-complementing adenoviral vectors for oncolytic therapy of malignant melanoma.
Wolkersdörfer GW; Morris JC; Ehninger G; Ramsey WJ
J Gene Med; 2004 Jun; 6(6):652-62. PubMed ID: 15170736
[TBL] [Abstract][Full Text] [Related]
33. Mode of transgene expression after fusion to early or late viral genes of a conditionally replicating adenovirus via an optimized internal ribosome entry site in vitro and in vivo.
Rivera AA; Wang M; Suzuki K; Uil TG; Krasnykh V; Curiel DT; Nettelbeck DM
Virology; 2004 Mar; 320(1):121-34. PubMed ID: 15003868
[TBL] [Abstract][Full Text] [Related]
34. Tissue-specific gene therapy directed to tumor angiogenesis.
Varda-Bloom N; Shaish A; Gonen A; Levanon K; Greenbereger S; Ferber S; Levkovitz H; Castel D; Goldberg I; Afek A; Kopolovitc Y; Harats D
Gene Ther; 2001 Jun; 8(11):819-27. PubMed ID: 11423929
[TBL] [Abstract][Full Text] [Related]
35. Coxsackievirus adenovirus receptor expression predicts the efficiency of adenoviral gene transfer into non-small cell lung cancer xenografts.
Qin M; Chen S; Yu T; Escuadro B; Sharma S; Batra RK
Clin Cancer Res; 2003 Oct; 9(13):4992-9. PubMed ID: 14581374
[TBL] [Abstract][Full Text] [Related]
36. Heat-directed gene targeting of adenoviral vectors to tumor cells.
Brade AM; Ngo D; Szmitko P; Li PX; Liu FF; Klamut HJ
Cancer Gene Ther; 2000 Dec; 7(12):1566-74. PubMed ID: 11228535
[TBL] [Abstract][Full Text] [Related]
37. Selective rat lung endothelial targeting with a new set of monoclonal antibodies to angiotensin I-converting enzyme.
Balyasnikova IV; Metzger R; Visintine DJ; Dimasius V; Sun ZL; Berestetskaya YV; McDonald TD; Curiel DT; Minshall RD; Danilov SM
Pulm Pharmacol Ther; 2005; 18(4):251-67. PubMed ID: 15777608
[TBL] [Abstract][Full Text] [Related]
38. Targeting an adenoviral gene vector to cytokine-activated vascular endothelium via E-selectin.
Harari OA; Wickham TJ; Stocker CJ; Kovesdi I; Segal DM; Huehns TY; Sarraf C; Haskard DO
Gene Ther; 1999 May; 6(5):801-7. PubMed ID: 10505104
[TBL] [Abstract][Full Text] [Related]
39. Viral transgene expression delivered by repeat intraocular adenoviral vector injection: in vivo live imaging study.
Gehlbach PL; Chuck RS; Park CG; Park CY
Mol Imaging; 2012; 11(5):361-71. PubMed ID: 22954180
[TBL] [Abstract][Full Text] [Related]
40. Sustained transgene expression by transfection of renin gene into liver of neonates.
Tomita N; Morishita R; Higaki J; Tomita S; Aoki M; Kaneda Y; Ogihara T
Biochem Biophys Res Commun; 1996 Jul; 224(1):43-9. PubMed ID: 8694831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
